Contingency management for the treatment of methamphetamine use disorders

American Journal of Psychiatry

Volumn 163, Issue 11, 2006, Pages 1993-1999

  Roll, John M ^a   Retry, Nancy M ^b   Stitzer, Maxine L ^b   Brecht, Mary L ^b   Peirce, Jessica M ^b   McCann, Michael J ^b   Blaine, Jack ^b   MacDonald, Marilyn ^b   DiMaria, Joan ^b   Lucero, Leroy ^b   Kellogg, Scott ^b  

^a WASHINGTON STATE UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; CANNABIS; COCAINE; METHAMPHETAMINE; OPIATE;

ADULT; ARTICLE; BEHAVIOR THERAPY; BREATH ANALYSIS; CLINICAL TRIAL; COGNITIVE THERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ABUSE; DRUG DEPENDENCE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PSYCHOSOCIAL CARE; RANDOMIZED CONTROLLED TRIAL; URINALYSIS;

EID: 33749467839     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/ajp.2006.163.11.1993     Document Type: Article

References (42)

1. Anglin MD, Burke C, Perrochet B, Stamper E, Dawud-Noursi S: History of the methamphetamine problem. J Psychoactive Drugs 2000; 32:137-141
2. Rawson RA, Gonzales R, Brethen P: Treatment of methamphetamine use disorders: an update. J Subst Abuse Treat 2002; 23:145-150
3. Beyrer C, Razak MH, Jittiwutikarn J, Suriyanon V, Vongchak T, Srirak N, Kawichai S, Tovanabutra S, Rungruengthanakit K, Sawanpanyalert P, Sripaipan T, Celentano DD: Methamphetamine users in northern Thailand: changing demographics and risks for HIV and STD among treatment-seeking substance abusers. Int J STD AIDS 2004; 15:697-704
4. Shoptaw S, Reback CJ, Freese T: Patient characteristics, HIV serostatus, and risk behaviors among gay and bisexual males seeking treatment for methamphetamine abuse and dependence in Los Angeles. J Addict Dis 2002; 21:91-105
5. Freese TE, Miotto K, Reback CJ: The effects and consequences of selected club drugs. J Subst Abuse Treat 2002; 23:151-156
6. Tominaga GT, Garcia G, Dzierba A, Wog J: Toll of methamphetamine on the trauma system. Arch Surg 2004; 139:844-847
7. Zweben JE, Cohen JB, Christian D, Galloway GP, Salinardi M, Parent D, Iguchi M: Methamphetamine Treatment Project: Psychiatric symptoms in methamphetamine users. Am J Addict 2004; 13:181-190
8. Danks RR, Wibbenmeyer LA, Faucher LD, Sihler KC, Kealey GP, Chang P, Amelon M, Lewis RW: Methamphetamine-associated burn injuries: a retrospective analysis. J Burn Care Rehabil 2004; 25:425-429
9. Kashani J, Ruha AM: Methamphetamine toxicity secondary to intravaginal body stuffing. J Toxicol Clin Toxicol 2004; 42:987-989
10. Reback CJ, Larkins S, Shoptaw S: Changes in the meaning of sexual risk behaviors among gay and bisexual male methamphetamine abusers before and after drug treatment. AIDS Behav 2004; 8:87-98
11. Kalechstein AD, Newton TF, Green M: Methamphetamine dependence is associated with neurocognitive impairment in the initial phases of abstinence. J Neuropsychiatry Clin Neurosci 2003; 15:215-220
12. Simon SL, Dacey J, Rawson R, Ling W: The effect of relapse on cognition in abstinent methamphetamine abusers. J Subst Abuse Treat 2004; 27:59-66
13. Newton TF, Kalechstein AD, Duran S, Vansluis N, Ling W: Methamphetamine abstinence syndrome: preliminary findings. Am J Addict 2004; 13:248-255
14. Wang GJ, Volkow ND, Chang L, Miller E, Sedler M, Hitzemann R, Zhu W, Logan J, Ma Y, Fowler JS: Partial recovery of brain metabolism in methamphetamine abusers after protracted abstinence. Am J Psychiatry 2004; 161:242-248
15. Copeland AL, Sorensen JL: Differences between methamphetamine users and cocaine users in treatment. Drug Alcohol Depend 2001; 62:91-95
16. Cretzmeyer M, Sarrazin MV, Huber DL, Block RI, Hall JA: Treatment of methamphetamine abuse: research findings and clinical directions. J Subst Abuse Treat 2003; 24:267-277
17. Rawson R, Huber A, Brethen P, Obert J, Gulati V, Shoptaw S, Ling W: Methamphetamine and cocaine users: differences in characteristics and treatment retention. J Psychoactive Drugs 2000; 32:233-238
18. Simon SL, Richardson K, Dacey J, Glynn S, Domier CP, Rawson RA, Ling W: A comparison of patterns of methamphetamine and cocaine use. J Addict Dis 2002; 21:35-44
19. Yen CF, Wu HY, Yen JY, Ko CH: Effects of brief cognitive-behavioral interventions on confidence to resist the urges to use heroin and methamphetamine in relapse-related situations. J Nerv Ment Dis 2004; 192:788-791
20. Rawson RA, Marinelle-Casey P, Anglin MD, Dickow A, Frazier Y, Gallagher C, Galloway G P, Herrell J, Huber A, McCann MJ, Obert J, Penell S, Reiber C, Vandersloot D, Zweben J: Methamphetamine Treatment Project Corporate Authors: A multi-site comparison of psychosocial approaches for the treatment of methamphetamine dependence. Addiction 2004; 99:708-717
21. Galloway GP, Newmeyer J, Knapp T, Stalcup SA, Smith D: Imipramine for the treatment of cocaine and methamphetamine dependence. J Addict Dis 1994; 13:201-216
22. Haney M, Kposten TR: Therapeutic vaccines for substance dependence. Expert Rev Vaccines 2004; 3:11-18
23. Bigelow GE, Silverman K: Theoretical and empirical foundations of contingency management treatments for drug abuse, in Motivating Behavior Change Among Illicit-Drug Abusers: Research on Contingency Management Interventions. Edited by Higgins ST, Silverman K. Washington, DC, American Psychological Association, 1999, pp 15-31
24. Higgins ST: The influence of alternative reinforcers on cocaine use and abuse: a brief review. Pharmacol Biochem Behav 1997; 57:419-427
25. Higgins ST, Heil SH, Plebani-Lussier J: Clinical implications of reinforcement as a determinate of substance use disorders. Annu Rev Psychol 2004; 55:431-461
26. Carroll ME, Lac ST, Nygaard SL: A concurrently available non-drug reinforcer prevents the acquisition or decreases the maintenance of cocaine-reinforced behavior. Psychopharmacology (Berl) 1989; 97:23-29
27. Higgins ST, Bickel WK, Hughes JR: Influence of an alternative reinforcer on human cocaine self-administration. Life Sci 1994; 55:179-187
28. Nader MA, Woolverton WL: Effects of increasing the magnitude of an alternative reinforcer on drug choice on a discrete-trials choice procedure. Psychopharmacology (Berl) 1991; 105:169-174
29. Prendergast M, Podus D, Finney J, Greenwell L, Roll J: Contingency management for treatment of substance use disorders: a meta-analysis. Addiction (in press)
30. Roll JM, Newton T: Contingency management for the treatment of methamphetamine use disorders, in Contingency Management in the Treatment of Substance Use Disorders: A Science-Based Treatment Innovation. Edited by Higgins ST, Silverman K, Hiel SH. New York, Guilford (in press)
31. Roll JM, Huber A, Sodano R, Chudzynski J, Moynier E, Shoptaw S: A comparison of five reinforcement schedules for use in contingency management-based treatment of methamphetamine abuse. Psychol Rec 2006; 56:67-81
32. Roll JM, Shoptaw S: Contingency management: schedule effects. Psychiatr Res 2006; 144:91-93
33. Shoptaw S, Reback CJ, Peck JA, Yang X, Rotheram-Fuller E, Larkins S, Veniegas RC, Freese TE, Hucks-Ortiz C: Behavioral treatment approaches for methamphetamine dependence and HIV-related sexual risk behaviors among urban gay and bisexual men. Drug Alcohol Depend 2005; 78:125-134
34. Shoptaw S, Huber A, Peck J, Yang X, Liu J, Jeff Dang, Roll J, Shapiro B, Rotheram-Fuller E, Ling W: Randomized, placebo-controlled trial of sertraline and contingency management for the treatment of methamphetamine dependence. Drug Alcohol Depend 2006; 85:12-18; Epub 2006, Apr 18
35. Peirce JM, Retry NM, Stitzer ML, Blaine J, Kellogg S, Satterfield F, Schwartz M, Krasnansky J, Pencer E, Silva-Vazquez L, Kirby KC, Royer-Malvestuto C, Roll JM, Cohen A, Copersino ML, Kolodner K, Li R: Effects of lower-cost incentives on stimulant abstinence in methadone maintenance treatment: a National Drug Abuse Treatment Clinical Trials Network study. Arch Gen Psychiatry 2006; 63:201-208
36. Petry NM, Martin B: Low-cost contingency management for treating cocaine- and opioid-abusing methadone patients. J Consult Clin Psychol 2002; 70:398-405
37. Petry NM, Tedford J, Austin M, Nich C, Carroll KM, Rounsaville BJ: Prize reinforcement contingency management for treating cocaine users: how low can we go, and with whom? Addiction 2004; 99:349-360
38. Petry NM, Martin B, Simcic F Jr: Prize reinforcement contingency management for cocaine dependence: integration with group therapy in a methadone clinic. J Consult Clin Psychol 2005; 73:354-359
39. Rawson RA, Shoptaw SJ, Obert JL, McCann MJ, Hasson AL, Marinelli-Casey PJ, Brethen PR, Ling W: An intensive outpatient approach for cocaine abuse treatment: the matrix model. J Subst Abuse Treat 1996; 12:117-127
40. Roll JM, Higgins ST: A within-subject comparison of three different schedules of reinforcement of drug abstinence using cigarette smoking as an exemplar. Drug Alcohol Depend 2000; 58:103-109
41. Moore BA, Budney AJ: Abstinence at intake for marijuana dependence treatment predicts response. Drug Alcohol Depend 2002; 67:249-257
42. Higgins ST, Badger GJ, Budney AJ: Initial abstinence and success in achieving longer term cocaine abstinence. Exp Clin Psychopharmacol 2000; 8:377-386